Oral GLP-1RAs for Diabetes and Obesity Show Promise but Have Gastrointestinal Drawbacks
by New research has revealed promising results for two orally administered glucagon-like peptide 1 receptor agonists (GLP-1RAs) in the treatment of type 2 diabetes mellitus and …